The biopharmaceutical company is in for a deeper bear phase. 
It appears that Amgen's share price erosion may continue given its performance in recent weeks. 

Intermediate Trade: Amgen Real Money Pro($)

AMGN's charts show 3 bullish divergences; try a call spread to take advantage.
We anticipate that price rallies in the prior support area ($105 to $110) fail and become new resistance. 
Buyers should stay on the sidelines of Bard until a base is formed, potentially at a lower level.
Prices could find some support or buying interest at $80.
Is the biotech company's stock on its way higher?
The stock may be on its way higher.
Here's a single-payer system that works pretty well.
BIIB needs to announce some top-line suprises when it reports on Wednesday to spark investor enthusiasm.

Columnist Conversations

The support line of the large horizontal channel on the S&P 500 weekly chart is being tested again and its...
CME Group (CME) raised it quarterly payout by 20%, from 50-cents to 60-cents. Dunkin' Brands (DNKN) increased ...
Johnson & Johnson (JNJ) saw a $15,762,000 sale (151,000 shares) at about a $104.10 average price. JNJ clos...
Today's Wall Street Journal noted these purchases in stocks I've written up positively in recent days. Feb 1, ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.